Sarepta Therapeutics (SRPT)

Trade SRPT now with
1/2/2019 8:33:22 AM Sarepta Therapeutics, Aldevron Enter Long-term Strategic Relationship For Supply Of Plasmid DNA
12/20/2018 8:31:51 AM Sarepta Completes Submission Of New Drug Application Seeking Approval Of Golodirsen
12/11/2018 8:31:02 AM Sarepta Therapeutics Appoints Mary Ann Gray To Its Board
11/7/2018 4:22:20 PM Sarepta Therapeutics To Sell $500 Mln In Shares Of Common Stock In Public Offering
10/24/2018 4:12:17 PM Sarepta Therapeutics Q3 Loss/share $1.15 Vs. Loss $0.78 Year Ago
10/15/2018 9:06:40 AM Sarepta And Lysogene Announce Exclusive License Agreement For LYS-SAF302
10/15/2018 8:02:12 AM Sarepta And Lysogene Announce License Agreement For LYS-SAF302
10/8/2018 8:31:08 AM Sarepta Therapeutics Enters Long-term Strategic Manufacturing Partnership With Paragon Bioservices
10/5/2018 8:33:53 AM Sarepta Announces Agreement With Nationwide Children’s Hospital For Rights To Its Gene Therapy Program
9/28/2018 6:05:30 PM Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/24/2018 7:03:04 AM Sarepta Announces Clinical Hold Lifted For Its Duchenne Muscular Dystrophy Micro-dystrophin Gene Therapy Program